Draft:Novonesis

Danish biotechnology company From Wikipedia, the free encyclopedia

Novozymes A/S (doing business as Novonesis)[2] is a biotechnology company headquartered in Lyngby, Denmark. It was established in 2024 following the merger of Novozymes and Chr. Hansen. The company develops enzymes, microbiological cultures, and other biological products used in industries such as food and beverage, agriculture, and energy. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation.[3]

  • Comment: It is OK to have purely offline references, but if that is done there needs to be full details of how to locate the sources. As it happens, at least some of these sources appear to be available online, but not linked into the article correctly, so I would assume this is a mistake of some sort. At the moment it is not possible to assess notability, for companies it is not always easy to get over the notability hurdle, the submitting editor needs to consider WP:NCORP / WP:SIRS. ChrysGalley (talk) 19:50, 19 November 2025 (UTC)
  • Comment: Why do none of the references have links? sus pythoncoder (talk | contribs) 18:41, 31 October 2025 (UTC)

Quick facts Trade name, Company type ...
Novozymes A/S
Novonesis
Company typePublicly traded Aktieselskab
Nasdaq Nordic: NSIS-B
ISINDK0060336014
IndustryBiotechnology
Predecessor
FoundedJanuary 29, 2024; 2 years ago (2024-01-29)
HeadquartersLyngby, Denmark
ProductsEnzymes, microbiological cultures, biopharmaceutical ingredients, human milk oligosaccharides
Revenue
  • Increase 3,833.5 million
 (2024)
 (2024)
  • Decrease305.8 million
 (2024)
ParentNovo Holdings A/S
Websitenovonesis.com
Footnotes / references
[1]
Close

History

Novonesis was founded on January 29, 2024, following a merger between Novozymes and Chr. Hansen, two Danish companies specializing in biotechnology.[4][5] The merger was first announced on December 12, 2022[4][6] and would result in Novozymes being the surviving legal entity of the two organizations.[6][2] Press material stated that the name "Novonesis" reflected the combination of "novo," meaning "new" in Latin, and "genesis," meaning "origin" or "beginning."[4]

Novozymes was known for producing industrial enzymes used in applications such as detergents[7], biofuels, and food production.[8] Chr. Hansen specialized in bacterial cultures for use in dairy products, probiotics, and agricultural solutions.[9]

The merger created one of the largest biotechnology companies in Denmark, with a combined product portfolio encompassing enzymes, microbial cultures, and other products for a variety of industries.[5]

In 2025, Novonesis reached an agreement with DSM-Firmenich to acquire its shares of the Feed Enzyme Alliance.[10]

Activities

As of 2024, Novonesis has over 10,000 employees and has activities in over 45 countries.[1] The merged Novonesis has its headquarters in Lyngby[11] but maintains a presence in other locations in Denmark.[4]

Company activities are divided into two divisions: Food and Health Biosolutions and Planetary Health Biosolutions.[1]

Governance and ownership

Novo Holdings A/S, the holding company of the Novo Nordisk Foundation, owns approximately 25% of the company's shares, corresponding to about 65% of its voting rights.[3][12]

See also

References

Related Articles

Wikiwand AI